Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
35.45
-0.88 (-2.41%)
Aug 24, 2026, 12:35 PM EDT - Market open
Phibro Animal Health Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 1,500 | 1,296 | 1,018 | 977.89 | 942.26 | 833.35 | |
Revenue Growth | 25.98% | 27.37% | 4.07% | 3.78% | 13.07% | 4.12% |
Cost of Revenue | 1,011 | 890.59 | 704.07 | 679.65 | 656.55 | 561.97 |
Gross Profit | 488.62 | 405.62 | 313.61 | 298.24 | 285.72 | 271.38 |
Selling, General & Admin | 300.65 | 269.68 | 247.09 | 223.35 | 183.53 | 193.82 |
Research & Development | - | - | - | - | 20.83 | - |
Amortization of Goodwill & Intangibles | 2.38 | 2.38 | 2.99 | 3.05 | 2.98 | 2.69 |
Operating Expenses | 303.02 | 272.06 | 250.07 | 226.39 | 207.34 | 196.51 |
Operating Income | 185.6 | 133.56 | 63.54 | 71.85 | 78.38 | 74.87 |
Interest Expense | -44.73 | -35.26 | -23.01 | -18.68 | -12.69 | -12.7 |
Interest & Investment Income | 1.88 | 2.62 | 4.47 | 3.36 | 0.82 | 0.84 |
Currency Exchange Gain (Loss) | -8.25 | -7.87 | -23.86 | -2.46 | 5.22 | 4.48 |
EBT Excluding Unusual Items | 134.49 | 93.05 | 21.14 | 54.07 | 71.72 | 67.49 |
Merger & Restructuring Charges | -9.5 | -25.98 | -6.93 | - | -0.6 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | 1.2 | - |
Legal Settlements | - | - | -4.2 | - | - | - |
Other Unusual Items | - | -1.96 | - | - | - | -1.02 |
Pretax Income | 128.85 | 67.99 | 10.92 | 54.07 | 72.33 | 66.47 |
Income Tax Expense | 33.62 | 19.73 | 8.5 | 21.47 | 23.15 | 12.08 |
Net Income | 95.23 | 48.26 | 2.42 | 32.61 | 49.18 | 54.39 |
Net Income to Common | 95.23 | 48.26 | 2.42 | 32.61 | 49.18 | 54.39 |
Net Income Growth | 199.55% | 1897.68% | -92.59% | -33.69% | -9.58% | 62.09% |
Shares Outstanding (Basic) | 41 | 41 | 41 | 41 | 41 | 40 |
Shares Outstanding (Diluted) | 41 | 41 | 41 | 41 | 41 | 41 |
Shares Change | 0.62% | 0.38% | 0.05% | - | - | - |
EPS (Basic) | 2.35 | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 |
EPS (Diluted) | 2.33 | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 |
EPS Growth | 198.65% | 1895.04% | -92.59% | -33.47% | -9.70% | 61.57% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 12.77 | 41.83 | 46.36 | -38.48 | -5.4 | 18.99 |
Free Cash Flow Per Share | 0.31 | 1.03 | 1.14 | -0.95 | -0.13 | 0.47 |
Dividend Per Share | 0.480 | 0.480 | 0.480 | 0.480 | 0.480 | 0.480 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 32.57% | 31.29% | 30.82% | 30.50% | 30.32% | 32.56% |
Operating Margin | 12.37% | 10.30% | 6.24% | 7.35% | 8.32% | 8.98% |
Profit Margin | 6.35% | 3.72% | 0.24% | 3.33% | 5.22% | 6.53% |
Free Cash Flow Margin | 0.85% | 3.23% | 4.55% | -3.94% | -0.57% | 2.28% |
EBITDA | 234.75 | 177.75 | 98.28 | 104.4 | 110.04 | 105.5 |
EBITDA Margin | 15.65% | 13.71% | 9.66% | 10.68% | 11.68% | 12.66% |
D&A For EBITDA | 49.16 | 44.18 | 34.74 | 32.56 | 31.66 | 30.63 |
EBIT | 185.6 | 133.56 | 63.54 | 71.85 | 78.38 | 74.87 |
EBIT Margin | 12.37% | 10.30% | 6.24% | 7.35% | 8.32% | 8.98% |
Effective Tax Rate | 26.09% | 29.02% | 77.87% | 39.70% | 32.01% | 18.18% |